Bromuro DE Umeclidinio

Resumen

Alternativas con registro en Colombia

• Ipatropio Bromuro · costo anual estimado $ 186.515
• Tiotropio Bromuro · costo anual estimado $ 421.940
• Bromuro DE Glicoperronio · costo anual estimado $ 1.215.815

Estudios clínicos principales

• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily
  Fase 3 · 2014 · 10.355 participantes · GlaxoSmithKline · NCT02164513
• DB2113361: A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD
  Fase 3 · 2011 · 1.493 participantes · GlaxoSmithKline · NCT01313637
• A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromid
  Fase 3 · 2016 · 2.436 participantes · GlaxoSmithKline · NCT02924688
• Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstr
  Fase 3 · 2013 · 620 participantes · GlaxoSmithKline · NCT02119286

Enfermedades relacionadas

• Asma
• EPOC (enfermedad pulmonar obstructiva crónica)

Fuentes

• Etiqueta FDA (DailyMed): Anoro Ellipta
• EMA: Rolufta Ellipta (previously Rolufta)
• EMA: Elebrato Ellipta